Suntar Ipek, Sureda Antoni, Belwal Tarun, Sanches Silva Ana, Vacca Rosa Anna, Tewari Devesh, Sobarzo-Sánchez Eduardo, Nabavi Seyed Fazel, Shirooie Samira, Dehpour Ahmad Reza, Xu Suowen, Yousefi Bahman, Majidinia Maryam, Daglia Maria, D'Antona Giuseppe, Nabavi Seyed Mohammad
Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Etiler, Ankara 06330, Turkey.
Research Group in Community Nutrition and Oxidative Stress, Health Research Institute of the Balearic Islands (IdISBa), and CIBEROBN (Physiopathology of Obesity and Nutrition), University of Balearic Islands, Palma, Balearic Islands E-07122, Spain.
Acta Pharm Sin B. 2020 May;10(5):734-745. doi: 10.1016/j.apsb.2020.01.001. Epub 2020 Jan 8.
Peroxisome proliferator-activated receptor (PPAR) is a transcriptional coactivator that binds to a diverse range of transcription factors. PPAR coactivator 1 (PGC-1) coactivators possess an extensive range of biological effects in different tissues, and play a key part in the regulation of the oxidative metabolism, consequently modulating the production of reactive oxygen species, autophagy, and mitochondrial biogenesis. Owing to these findings, a large body of studies, aiming to establish the role of PGC-1 in the neuromuscular system, has shown that PGC-1 could be a promising target for therapies targeting neuromuscular diseases. Among these, some evidence has shown that various signaling pathways linked to PGC-1 are deregulated in muscular dystrophy, leading to a reduced capacity for mitochondrial oxidative phosphorylation and increased reactive oxygen species (ROS) production. In the light of these results, any intervention aimed at activating PGC-1 could contribute towards ameliorating the progression of muscular dystrophies. PGC-1 is influenced by different patho-physiological/pharmacological stimuli. Natural products have been reported to display modulatory effects on PPAR activation with fewer side effects in comparison to synthetic drugs. Taken together, this review summarizes the current knowledge on Duchenne muscular dystrophy, focusing on the potential effects of natural compounds, acting as regulators of PGC-1.
过氧化物酶体增殖物激活受体(PPAR)是一种转录共激活因子,可与多种转录因子结合。PPAR共激活因子1(PGC-1)在不同组织中具有广泛的生物学效应,在氧化代谢调节中起关键作用,从而调节活性氧的产生、自噬和线粒体生物发生。基于这些发现,大量旨在确定PGC-1在神经肌肉系统中作用的研究表明,PGC-1可能是治疗神经肌肉疾病的一个有前景的靶点。其中,一些证据表明,与PGC-1相关的各种信号通路在肌肉营养不良中失调,导致线粒体氧化磷酸化能力降低和活性氧(ROS)产生增加。鉴于这些结果,任何旨在激活PGC-1的干预措施都可能有助于改善肌肉营养不良的进展。PGC-1受不同病理生理/药理刺激的影响。据报道,天然产物对PPAR激活具有调节作用,与合成药物相比副作用较少。综上所述,本综述总结了目前关于杜氏肌营养不良症的知识,重点关注作为PGC-1调节剂的天然化合物的潜在作用。